ATNF | tickerfilter.com

Fundamental analysis

25%

Profitability 0%

Dept financing 49%

Liquidity 0%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-9.70%

1 Month

-29.68%

3 Months

-47.38%

6 Months

-32.66%

1 Year

-65.68%

2 Year

-34.33%

Key data

Stock price

$0.79

P/E Ratio

0.00

DAY RANGE

$0.75 - $0.85

EPS

-$5.76

52 WEEK RANGE

$0.75 - $17.75

52 WEEK CHANGE

-$65.75

MARKET CAP

1.638 M

YIELD

N/A

SHARES OUTSTANDING

969.602 K

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-15-2025

BETA

1.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$55,386

AVERAGE 30 VOLUME

$41,384

Company detail

CEO: Jim N. Woody
Region: US
Website: 180lifesciences.com
Employees: 7
IPO year: 2017

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

1180 Life Sciences Corp. develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

ATNF - 180 Life Sciences Corp.